专题：Ocular Diseases and Behçet’s Syndrome

This cluster of papers focuses on the epidemiology, diagnosis, and management of ocular inflammatory diseases, particularly uveitis and Behçet's disease. It covers topics such as the use of immunosuppressive drugs, anti-TNF therapy, and interferon alpha2a therapy in the treatment of these conditions. Additionally, it discusses the epidemiological patterns and prevalence of ocular inflammatory diseases, including their association with juvenile idiopathic arthritis.
最新文献
Ultrawide-field swept-source optical coherence tomography angiography reveals systemic vascular biomarkers in systemic lupus erythematosus: clinical associations with disease activity.

article Full Text OpenAlex

Case Report: A rare case of Epstein–Barr virus mucocutaneous ulcers occurring in the eyeball and literature review

article Full Text OpenAlex

Clinical and Multimodal Imaging Findings in Extensive Macular Atrophy With Pseudodrusen (EMAP): A Systematic Review and Meta-Analysis

article Full Text OpenAlex

Prevalence and associations of central serous chorioretinopathy in a population aged 50+ years. The Beijing Eye Study

article Full Text OpenAlex

Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis

article Full Text OpenAlex

Evaluating the usefulness of ChatGPT and Gemini in generating educational content for patients with vitiligo: a comparative cross-sectional study

article Full Text OpenAlex

Non-Neoplastic Disorders Mimicking Anterior Uveitis

article Full Text OpenAlex

Linking the microbiome to the complement system in geographic atrophy

article Full Text OpenAlex

Assessing the prevalence of extensive macular atrophy with pseudodrusen-like appearance in patients with rheumatic fever-associated valvular heart disease: a cross-sectional study

article Full Text OpenAlex

Behçet's Disease: A Comprehensive Overview of Symptoms, Pathology, Genetics, and Treatment.

article Full Text OpenAlex

近5年高被引文献
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

article Full Text OpenAlex 625 FWCI117.2106

Diagnosis and classification of optic neuritis

review Full Text OpenAlex 263 FWCI35.5078

Ocular Drug Delivery: a Comprehensive Review

review Full Text OpenAlex 256 FWCI29.2602

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

review Full Text OpenAlex 218 FWCI33.8384

Autophagy in age-related macular degeneration

review Full Text OpenAlex 211 FWCI44.9239

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

review Full Text OpenAlex 185 FWCI47.8952

Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment

review Full Text OpenAlex 184 FWCI25.3837

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

review Full Text OpenAlex 177 FWCI29.1146

miR-204–containing exosomes ameliorate GVHD-associated dry eye disease

article Full Text OpenAlex 157 FWCI28.7322

KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema

article Full Text OpenAlex 156 FWCI30.6299